Paromomycin

An aminoglycoside antibiotic derived from Streptomyces rimosus var. paromomycinus, with amebicidal and antibacterial activity. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation, thereby leading to inhibition of protein synthesis followed by cell death.

• Publication year

  2020

• Venue

  Definitions

• Publication date

  2020-02-07

• Fields of study

  Not labeled

• Identifiers
  DOI 10.32388/r6brql
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Progress in antileishmanial drugs: Mechanisms, challenges, and prospects

  2025cites this paper
• Targeting Trypanothione Synthetase and Trypanothione Reductase: Development of Common Inhibitors to Tackle Trypanosomatid Disease

  2025cites this paper
• Molecular-level strategic goals and repressors in Leishmaniasis - Integrated data to accelerate target-based heterocyclic scaffolds.

  2023cites this paper
• Pharmacoinformatics insight into the biological activity of medicinal plants to treat topical and systemic infections of MRSA

  2023cites this paper
• Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022)

  2023cites this paper
• Pyrolysis behaviour of shellfish waste via TG-FTIR and Py-GC/MS

  2023cites this paper
• Natural products as anthelmintics: safeguarding animal health.

  2023cites this paper
• Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection.

  2022cites this paper
• Krebs cycle enzymes for targeted therapeutics and immunotherapy for anti-leishmanial drug development using: Pathways, potential targets, and future perspectives.

  2022cites this paper
• Drug-Repurposing Approach To Combat Staphylococcus aureus: Biomolecular and Binding Interaction Study

  2022cites this paper
• Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue.

  2022cites this paper
• The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018

  2022cites this paper
• Carbohydrate-based drugs launched during 2000−2021

  2022cites this paper
• Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis

  2022cites this paper
• Antileishmanial Drug Discovery and Development: Time to Reset the Model?

  2021cites this paper
• Potential for the Development of a New Generation of Aminoglycoside Antibiotics

  2021cites this paper
• Aminoglycoside Antibiotics

  2021cites this paper
• Multinuclear Nuclear Magnetic Resonance Spectroscopy Is Used to Determine Rapidly and Accurately the Individual pKa Values of 2-Deoxystreptamine, Neamine, Neomycin, Paromomycin, and Streptomycin

  2021cites this paper
• Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses

  2021cites this paper
• Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?

  2020cites this paper
• Computational approaches for drug discovery against trypanosomatid-caused diseases

  2020cites this paper
• Highly sensitive UPLC-MS/MS method for the quantification of paromomycin in human plasma.

  2020cites this paper
• A perspective on the discovery of selected compounds with anthelmintic activity against the barber's pole worm-Where to from here?

  2020cites this paper
• Xanthine Oxidase Inhibitory Activity, Chemical Composition, Antioxidant Properties and GC-MS Analysis of Keladi Candik (Alocasia longiloba Miq)

  2020cites this paper
• Sand Fly Studies Predict Transmission Potential of Drug-resistant Leishmania.

  2020cites this paper
• Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo

  2020cites this paper
• Susceptibility to paromomycin in clinical isolates and reference strains of Leishmania species responsible for tegumentary leishmaniasis in Brazil.

  2020cites this paper
• Paromomycin sulfate is an effective treatment for balantidiasis in captive cynomolgus monkeys

  2019cites this paper
• Identification of Phenylphthalazinones as a New Class of Leishmania infantum Inhibitors

  2019cites this paper
• The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major May Be Involved in the Resistance to Drugs such as Paromomycin

  2019cites this paper
• Genomic and Metabolomic Polymorphism among Experimentally Selected Paromomycin-Resistant Leishmania donovani Strains

  2019cites this paper
• Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection

  2019cites this paper
• Allergic contact dermatitis caused by paromomycin

  2019cites this paper
• Repurposed Molecules: A New Hope in Tackling Neglected Infectious Diseases

  2019cites this paper
• Chemotherapeutic options for the treatment of human trichomoniasis.

  2019cites this paper
• Structure‐Based Design of a Eukaryote‐Selective Antiprotozoal Fluorinated Aminoglycoside

  2018cites this paper
• Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs

  2018cites this paper
• Metronidazole‐resistant trichomoniasis: beneficial pharmacodynamic relationship with high‐dose oral tinidazole and vaginal paromomycin combination therapy: 3

  2018cites this paper
• GC-MS analysis and antimicrobial effects of methanol stem bark extract of Trilepisium madagascriense DC.

  2017cites this paper
• Antileishmanial activity of medicinal plants from Africa: A review

  2017cites this paper
• Investigation of in vitro absorption, distribution, metabolism, and excretion and in vivo pharmacokinetics of paromomycin: Influence on oral bioavailability

  2017cites this paper
• Quimioterapia Antileishmania: Uma Revisão da Literatura

  2016cites this paper
• Abordagem terapêutica da Leishmaniose Visceral no Brasil - revisão para clínicos Therapeutic approach of Visceral Leishmaniasis in Brazil - a review for the clinicians

  2015cites this paper
• Genetic Reconstruction of Protozoan rRNA Decoding Sites Provides a Rationale for Paromomycin Activity against Leishmania and Trypanosoma

  2011cites this paper